114 results match your criteria: "Tokyo Kita Medical Center[Affiliation]"
Epilepsy Behav Rep
September 2024
Department of Pediatrics, National Epilepsy Center, NHO Shizuoka Institute of Epilepsy and Neurological Disorders, 886, Urushiyama, Aoi-ku, Shizuoka 420-8688, Japan.
PLoS One
September 2024
Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Pediatr Int
September 2024
Department of Pediatric Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
BMC Nephrol
August 2024
Department of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Background: Lifestyle modifications by educational sessions are an important component of multidisciplinary treatment for chronic kidney disease (CKD). We attempted to identify the best method to teach these modifications in order to ensure their acceptance by patients and investigated its effectiveness in CKD practice.
Methods: This study is a post-hoc analysis of the FROM-J study.
J Stroke Cerebrovasc Dis
November 2024
Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan. Electronic address:
Neurosurgery
August 2024
Department of Endovascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan.
Background And Objectives: Although intraprocedural rupture (IPR) is rare, it is a devastating complication of endovascular treatment (EVT) for intracranial aneurysms. Very few studies have been conducted on IPR, and the safety and efficacy of management techniques of IPR have not been investigated.
Methods: Patients who experienced IPR during EVT between 2013 and 2022 were enrolled from a multicenter observational registry.
Cureus
June 2024
Department of Hematology, Tokyo Kita Medical Center, Tokyo, JPN.
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy affecting multiple sites, most commonly the skin. About 10-20% of BPDCN cases are accompanied by hematological neoplasms. A 71-year-old male was diagnosed with chronic myeloid leukemia in the chronic phase (CML-CP) 11 years prior (at 60 years of age), and dasatinib treatment was initiated.
View Article and Find Full Text PDFReprod Sci
October 2024
Department of Obstetrics and Gynecology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Pravastatin is a promising medication to treat preeclampsia. However, the appropriate dose of pravastatin for managing preeclampsia has not been established. In this in vitro study, we examined the effects of low concentrations of pravastatin (0.
View Article and Find Full Text PDFClin Neurol Neurosurg
July 2024
Department of Endovascular Surgery, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan. Electronic address:
Int J Clin Oncol
August 2024
Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Cancer Sci
July 2024
Division of Clinical Laboratory Medicine, Department of Multidisciplinary Internal Medicine, Tottori University, Yonago, Japan.
Auris Nasus Larynx
June 2024
Jichi Ika University Saitama Medical Center, Department of Otolaryngology-Head and Neck Surgery, Saitama city, Japan.
Objective: Cholesteatoma secondary to tympanic perforation, known as "secondary acquired cholesteatoma" may progress slower than a retraction pocket cholesteatoma, with less bone destruction and fewer intracranial complications. However, complete surgical removal remains difficult because the pathological epithelium on the marginal side of the extension is not covered by the subepithelial layer of the cholesteatoma matrix, making the boundary with the middle ear mucosa difficult to identify. Therefore, considering the pathophysiology of secondary acquired cholesteatoma, suitable preoperative evaluation and surgical techniques are required.
View Article and Find Full Text PDFWorld J Urol
March 2024
Department of Urology, The Jikei University School of Medicine, 3-19-18, Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8471, Japan.
Objective: We aimed to assess the impact of the timing of urinary drainage on clinical outcomes in patients with obstructive pyelonephritis (OPN) associated with upper urinary tract (UUT) stones.
Methods: We retrospectively evaluated the multicenter dataset of 240 patients with OPN associated with UUT stones who underwent urinary drainage. We divided the patients into two groups depending on the timing of urinary drainage; emergency drainage, defined as within 12 h from admission, and delayed drainage, defined as between 12 and 48 h from admission.
Gan To Kagaku Ryoho
February 2024
Dept. of Surgery, Tokyo-Kita Medical Center.
The case is a 73-year-old woman. She visited primary care doctor for abdominal pain, vomiting, diarrhea, and melena that persisted for 2 weeks. She was referred to our department because she had an elevated inflammatory response and CT showed a mass in her left upper quadrant.
View Article and Find Full Text PDFEndocrinol Diabetes Metab Case Rep
January 2024
Department of Family & General Medicine, Tokyo-Kita Medical Center, Japan.
JSES Int
January 2024
Department of Orthopedic Surgery, Shoulder Center, Tokyo KITA Medical Center, Tokyo, Japan.
J Med Case Rep
February 2024
Department of General Medicine, Faculty of Medicine, Juntendo University, 2-1-1, Bunkyo-ku, Tokyo, 113-8421, Japan.
Background: Tight filum terminale is a rare and challenging condition to diagnose because it presents with nonspecific symptoms and unclear imaging findings. This report documents an atypical case of tight filum terminale.
Case Presentation: The patient was a previously healthy Asian 18-year-old male presenting with recurrent upper extremity and back pain, initially treated as nonspecific musculoskeletal pain.
BMC Oral Health
February 2024
Department of Dysphagia Rehabilitation, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
Background: Xeroderma pigmentosum (XP) is an extremely rare and severe form of photosensitivity. It is classified into types A-G or V according to the gene responsible for the disease. The progression and severity of symptoms vary depending on the type.
View Article and Find Full Text PDFRinsho Ketsueki
January 2024
Department of Hematology, Tokyo-Kita Medical Center.
Here we present the case of a 50-year-old woman with chronic myeloid leukemia who received nilotinib as initial treatment. After about 2 years of nilotinib therapy, she developed headache, blurred vision, impaired consciousness, and marked hypertension. Posterior reversible encephalopathy syndrome (PRES) was diagnosed, and was strongly suspected to be a vascular adverse event caused by nilotinib.
View Article and Find Full Text PDFAuris Nasus Larynx
April 2024
Department of Otolaryngology, Deafness and Middle Ear Surgicenter Tokyo Kita Medical Center, 4-17-56, Akabanedai, Kita-ku, Tokyo 115-0053, Japan; Department of Otolaryngology Head and Neck Surgery, Jichi Medical University Saitama Medical Center 1-847, Amanuma-cho, Omiya 330-0834, Japan.
Objective: External auditory canal cholesteatoma (EACC) is characterized by retained squamous debris within the external canal and variable amounts of localized bone destruction. The etiology of primary EACC remains incompletely understood. This study was conducted to analyze the clinical features and backgrounds of patients with primary EACC and to clarify the risk factors for the occurrence and progression of EACC.
View Article and Find Full Text PDFJ Ren Nutr
March 2024
Department of Nephrology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan. Electronic address:
CEN Case Rep
April 2024
Department of Internal Medicine, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, Japan.
Transplant Cell Ther
November 2023
Division of Clinical Laboratory Medicine, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Tottori, Japan.
Autologous stem cell transplantation (ASCT) is the standard of care for myeloma patients who achieve partial response (PR) or better after induction therapy. However, its clinical significance in patients with suboptimal response (SR) before ASCT, including stable disease (SD) and progressive disease (PD), has not been established. Additionally, functional high-risk, including SR and early PD within 12 months, was a poor prognostic factor up to now.
View Article and Find Full Text PDFClin Neurol Neurosurg
August 2023
Department of Endovascular surgery, Tokyo Medical and Dental University, Tokyo, Japan. Electronic address: